Nanosonics Ltd. | Mutual Funds
Mutual Funds that own Nanosonics Ltd.
Fidelity Select Medical Equipment & Systems Portfolio
14,000,000
4.68%
1,100,000
0.64%
07/31/2018
Fidelity Series Small Cap Opportunities Fund
9,013,229
3.01%
552,981
0.36%
04/30/2018
Government Pension Fund - Global (The)
5,325,970
1.78%
2,206,657
0%
12/31/2017
Fidelity International Small Cap Fund
4,155,779
1.39%
621,600
0.53%
04/30/2018
Vanguard Total International Stock Index Fund
3,247,435
1.09%
0
0%
07/31/2018
Wasatch International Growth Fund
2,653,565
0.89%
0
0.4%
03/31/2018
Vanguard Australian Shares Index Fund
1,878,316
0.63%
49,353
0.05%
07/31/2018
Wasatch International Opportunities Fund
1,472,451
0.49%
0
0.71%
03/31/2018
Fidelity Stock Selector Small Cap Fund
1,414,191
0.47%
-930,767
0.28%
04/30/2018
iShares MSCI EAFE Small Cap ETF
1,399,597
0.47%
0
0.03%
09/06/2018
| Address |
14 Mars Road
Sydney New South Wales (NSW) 2066
Australia
|
|
Employees
|
- |
| Website |
http://www.nanosonics.com.au |
| Updated |
07/08/2019 |
| Nanosonics Ltd. engages in the research, development, and commercialization of infection control and decontamination products and related technologies. Its products platform include trophon EPR & NanoNebulant. The company was founded by Maurie Stang on November 14, 2000 and is headquartered in Alexandria, Australia. |
